摘要
C-藻蓝蛋白(C-PC)是一种来自海洋藻类的含色素蛋白质,在多种炎性疾病和肿瘤治疗中表现出良好的效果。其对药物或毒性物质引起的肝损害、非酒精性脂肪性肝病、肝纤维化和肝脏缺血再灌注损伤等多种肝病具有保护作用。C-PC对肝损伤的保护作用主要是通过调节核因子(NF)-κB、磷脂酰肌醇3激酶/蛋白激酶B(PI3K/Akt)和AMP依赖的蛋白激酶(AMPK)等信号通路及抑制氧化应激等机制实现的,且对正常细胞没有毒性。因此,C-PC作为一种潜在的天然保肝海洋活性物质具有广阔的应用前景。就近年来C-PC对肝脏损伤的保护作用及机制的研究进展进行综述。
C-phycocyanin(C-PC)is a pigmented protein from marine algae,which demonstrates fair therapeutic effects on a variety of inflammatory diseases and tumors.It also shows protective effects on various kinds of liver diseases,such as liver damage caused by drugs or toxic substances,non-alcoholic fatty liver disease,liver fibrosis and liver ischemiareperfusion injury.These beneficial effects on liver injury are mainly achieved by regulating the signal pathways of nuclear factor-κB(NF-κB),phosphatidylinositol 3 kinase/protein kinase B(PI3K/Akt)and adenosine monophosphate(AMP)-activated protein kinase(AMPK)and inhibiting oxidative stress.C-PC exhibits no toxicity to normal cells.Therefore,as a potential marine active substance for liver protection,C-PC has a broad application prospect.In this paper,the research progresses of the protective effect and mechanism of C-PC on different kinds of liver injury in recent years.
作者
吕康宁
王蕾
秦松
王莉
LYU Kangning;WANG Lei;QIN Song;WANG Li(School of Ocean,Yantai University,Yantai 264003,China;Yantai Institute of Coastal Zone Research,Chinese Academy of Sciences;Yantai Qishan Hospital)
出处
《天津医药》
CAS
北大核心
2022年第6期668-672,共5页
Tianjin Medical Journal
基金
国家重点研发项目(2018YFD0901102)
烟台市重点研发项目(2020MSGY084)。
关键词
蓝藻门
肝疾病
化学性与药物性肝损伤
再灌注损伤
肝肿瘤
非酒精性脂肪性肝病
C-藻蓝蛋白
CYANOPHYTA
liver diseases
chemical and drug induced liver injury
reperfusion injury
liver neoplasms
non-alcoholic fatty liver disease
C-phycocyanin